Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 410 (LINC00410) is a human long non-coding RNA gene consisting of a ~2,000 base pair transcript, not translated into protein[1][3]. As a member of the lncRNA family, it is classified as a non-protein coding RNA and its precise biological role is not well defined in the current scientific literature. LINC00410 is annotated in major databases (GeneCards, NCBI Gene, Ensembl) as a lncRNA, with no reported molecular functions, cellular pathways, or disease roles specific to this gene. It should not be confused with similarly named RNAs (such as LINC00460), which *do* have well-established roles in cancer biology and as potential biomarkers[2][4]. LINC00410 currently has no described function as a therapeutic target. If you require detailed information about a similarly named RNA, such as LINC00460 (which is known to be involved in cancer and is a proposed biomarker and ceRNA), please clarify, as LINC00410 and LINC00460 are distinct lncRNAs with different biological and clinical contexts[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 410 (LINC00410).